NT

Nektar Therapeutics

Organization

Heard in 2 episodes across 2 shows since Jun 2026

Nektar Therapeutics is an American biopharmaceutical company founded in 1990 and headquartered in San Francisco, California. It develops drug candidates using proprietary PEGylation and advanced polymer-conjugate technologies designed to improve characteristics such as drug retention and solubility, and has supplied technology to pharmaceutical companies.

Episodes

2
across 2 shows

First heard

Jun 2026

Expert statements

1
1 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20261
Jul 20260
Aug 20260
Sep 20260
Oct 20261
Nov 20260

Email alert

Email me when Nektar Therapeutics comes up on a podcast

One email a week at most, with the new episodes that mention Nektar Therapeutics. Free, no account needed, unsubscribe in one click.

What experts have said about Nektar Therapeutics

1 statement · 1 positive

  1. Matthew CloutierPositiveOct 10, 2026· Breaking Biotech

    Nektar’s sharp pullback appears unjustified and may present an opportunity.

    “Nektar, what has really changed? I don't know. I don't really get why the pullback was so dramatic, but I think it's an opportunity.”

    Listen at 23:38

    Open the episode · 118 - End of Week Wrap up - Oct 9, 2026

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring Nektar Therapeutics, newest first